Chlamydial infection, unspecified. A74.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM A74.9 became effective on October 1, 2018.
Diagnosis Index entries containing back-references to A56.2: ICD-10-CM Diagnosis Code A56.8 Infection, infected, infective (opportunistic) B99.9 ICD-10-CM Diagnosis Code B99.9 Chlamydia, chlamydial A74.9 ICD-10-CM Diagnosis Code A74.9 ICD-10-CM Codes Adjacent To A56.2...
183160: Chlamydia trachomatis,Neisseria gonorrhoeae, and Trichomonas vaginalis, NAA | Labcorp Skip to main content
Trachoma, unspecified. A71.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM A71.9 became effective on October 1, 2019. This is the American ICD-10-CM version of A71.9 - other international versions of ICD-10 A71.9 may differ.
The chlamydia cause respiratory infection manifested with fever, malaise, cough, dyspnea, sore throat, photophobia and headaches. Chlamydia is a common sexually transmitted disease caused by bacteria. You get it by having sex or sexual contact with someone who is infected. Both men and women can get it. Chlamydia usually doesn't cause symptoms.
Chlamydia is a common sexually transmitted disease. It is caused by bacteria called Chlamydia trachomatis. It can infect both men and women. Women can get chlamydia in the cervix, rectum, or throat.
ICD-10-CM Diagnosis Code A56 A56. 00 Chlamydial infection of lower genitourinary t...
ICD-10 code Z11. 3 for Encounter for screening for infections with a predominantly sexual mode of transmission is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Chlamydia trachomatis (/kləˈmɪdiə trəˈkoʊmətɪs/), commonly known as chlamydia, is a bacterium that causes chlamydia, which can manifest in various ways, including: trachoma, lymphogranuloma venereum, nongonococcal urethritis, cervicitis, salpingitis, pelvic inflammatory disease. C.
9: Fever, unspecified.
What are the appropriate ICD-10 codes for History of chlamydia in pregnancy? O98. 81x Other maternal infectious & parasitic disease complicating pregnancy, xxx trimester + Z86. 19 Personal history of other infectious and parasitic diseases?
This policy describes reimbursement for Infectious agent detection by nucleic acid (DNA or RNA) assays for the detection of Sexually Transmitted Infections (STI), represented by CPT codes 87491, 87591, 87661, or 87801, and submitted for reimbursement on professional and facility claim forms.
For claims for screening for syphilis in pregnant women at increased risk for STIs use the following ICD-10-CM diagnosis codes: • Z11. 3 - Encounter for screening for infections with a predominantly sexual mode of transmission; • and any of: Z72.
Z11. 3 - Encounter for screening for infections with a predominantly sexual mode of transmission | ICD-10-CM.
ChlamydiaeChlamydia trachomatis / Class
The Chlamydia trachomatis bacterium is most commonly spread through vaginal, oral and anal sex. It's also possible for pregnant women to spread chlamydia to their children during delivery, causing pneumonia or a serious eye infection in the newborns.
Chlamydia trachomatis also resides in the genital tract, cervix, and urethra of adults, and genital infection is spread sexually. Lymphogranuloma venereum persists in the genital tract of infected persons.
Chlamydia is a common sexually transmitted disease caused by bacteria. You get it by having sex or sexual contact with someone who is infected.
In women, infection of the reproductive system can lead to pelvic inflammatory disease, which can cause infertility or serious problems with pregnancy . Babies born to infected mothers can get eye infections and pneumonia from chlamydia.
Chlamydia screening among young women under the age of 26 is a measure that has been adopted by the National Committee for Quality Assurance (NCQA) for inclusion in the Health Plan Employer Data and Information Set (HEDIS).
Aetna considers home testing for C. trachomatis experimental and investigational because of insufficient evidence in the peer-reviewed literature.
Kamel et al (2013) stated that C. trachomatis infection is a worldwide-distributed sexually transmitted infection that may lead to infertility.
These sequelae are unfortunate because C. trachomatis infection is effectively treated with antibiotics. Diagnosis is based on the detection of the microorganism itself, its antigens, or genetic material collected from the lower genital tract, or in some instances, a urine sample.
Most C. trachomatis infections cause no symptoms. Left untreated, C. trachomatis infection can lead to complications such as pelvic inflammatory disease in the female, which has emerged as a major cause of tubal factor infertility and ectopic pregnancy in women of childbearing age.
The USPSTF made no recommendation for or against routine screening of asymptomatic, low-risk pregnant women aged 25 years and older for chlamydial infection. The USPSTF found fair evidence that the benefits of screening low-risk pregnant women are small and may not justify the possible harms.
Aetna considers Chlamydia trachomatis ( C. trachomatis) screening a medically necessary preventive service according to the recommendations of the National Institute for Health and Clinical Excellence, United States Preventive Services Task Force (USPSTF) and the Centers for Disease Control and Prevention (CDC).
People with chlamydia who have no symptoms can still pass the disease to others. If you do have symptoms, they may not appear until several weeks after you have sex with an infected partner. Symptoms in women include. Abnormal vaginal discharge, which may have a strong smell.
Valid for Submission. A56.3 is a billable diagnosis code used to specify a medical diagnosis of chlamydial infection of anus and rectum. The code A56.3 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
Chlamydia is a common sexually transmitted disease. It is caused by bacteria called Chlamydia trachomatis. It can infect both men and women. Women can get chlamydia in the cervix, rectum, or throat. Men can get chlamydia in the urethra (inside the penis), rectum, or throat.
Chlamydia infection (from the Greek, χλαμύδα meaning "cloak") is a common sexually transmitted infection in humans caused by the bacterium Chlamydia trachomatis. The term Chlamydia infection can also refer to infection caused by any species belonging to the bacterial family Chlamydiaceae. C. trachomatis is found only in humans.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
DRG Group #727-728 - Inflammation of the male reproductive system with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code A56.09. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code A56.09 and a single ICD9 code, 099.53 is an approximate match for comparison and conversion purposes.
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Vaginal, endocervical, or male urethral swab, first-void urine (patient should not have urinated for one hour prior to specimen collection), or cervical cells in liquid cytology vial.
One swab, 2 mL of a 20 mL to 30 mL urine collection, or entire liquid cytology vial
One swab, 2 mL of a 20 mL to 30 mL urine collection, or entire liquid cytology vial
Gen-Probe® Aptima® swab or Aptima® urine specimen transport; ThinPrep® liquid cytology vial
Vaginal swab collection: Care provider specimen: Collect vaginal fluid sample using the Gen-Probe® Aptima® Vaginal Swab Kit by contacting the swab to the lower third of the vaginal wall, rotating the swab for 10 to 30 seconds to absorb the fluid.
Specimen with incorrect patient identification; unlabeled specimen; inappropriate specimen transport conditions; specimens received after prolonged delay (usually >72 hours); specimen leaked in transit; specimen in expired transport or incorrect transport device; specimens with inappropriate source for test requested; specimen with fixative or additives; Aptima® urine transport >30 days from collection; Aptima® urine transport with incorrect specimen volume; <15 mL urine submitted in sterile container; receipt of urine in sterile container >24 hours from collection; Aptima® swab transport >60 days from collection; Aptima® swab specimens with incorrect specimen volume; Aptima® swab specimen without a swab; cleaning swab (white-shaft swab) in Aptima® swab transport; any non−Gen-Probe® swab submitted in Aptima® transport device; wooden-shaft swab in transport device; transport device with multiple swabs; female urethral swab; bloody or grossly mucoid specimens; bacterial swabs; specimen in ProbeTec™ UPT transport; ProbeTec™ Q-swabs; UTM-RT; SurePath™ vial.